{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:51:01Z","timestamp":1683075061324},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.diagmicrobio.2007.03.024","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T11:58:12Z","timestamp":1180526292000},"page":"75-80","source":"Crossref","is-referenced-by-count":6,"title":["Antimicrobial resistance among invasive isolates of Streptococcus pneumoniae collected across Canada"],"prefix":"10.1016","volume":"59","author":[{"given":"Ross J.","family":"Davidson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Melano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin R.","family":"Forward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","article-title":"The biological cost of antibiotic resistance","volume":"2","author":"Andersson","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"issue":"Suppl. 1A","key":"10.1016\/j.diagmicrobio.2007.03.024_bib2","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1016\/S0002-9343(99)00104-7","article-title":"Therapy for pneumococcal infection at the millennium: doubts and certainties","volume":"107","author":"Ball","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pbio.0030176","article-title":"Inhibition of mutation and combating the evolution of antibiotic resistance","volume":"3","author":"Cirz","year":"2005","journal-title":"PLOS Biol."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib4","series-title":"Clinical Laboratory Standards Institute. (2005). Performance Standards for Antimicrobial Susceptibility Testing: 15th Informational Supplement","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance tolevofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib7","unstructured":"Davidson RJ, Chan CK, Doern G, Zhanel GG. Abstr. 13th Eur. Congress Clin. Microbiol. Infect. Dis, Abstr 1736, 2003."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib8","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1128\/AAC.43.9.2144","article-title":"Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada","volume":"43","author":"de Azavedo","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib9","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","article-title":"Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program","volume":"27","author":"Doern","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib10","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/AAC.45.6.1721-1729.2001","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999\u20132000, including a comparison of resistance rates since 1994\u20131995","volume":"45","author":"Doern","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/588389","article-title":"Pneumonia treatment failure associated with highly resistant pneumococci","volume":"29","author":"Dowell","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in theera of antibiotic resistance, 1995\u20131997","volume":"90","author":"Feikin","year":"2000","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jac\/45.2.191","article-title":"The Alexander project 1996\u20131997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections","volume":"45","author":"Felmingham","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00063198-199703000-00002","article-title":"Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia","volume":"3","author":"File Jr","year":"1997","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s001340050816","article-title":"Epidemiological features and prognosis of severe community-acquired pneumococcal pneumonia","volume":"25","author":"Georges","year":"1999","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib16","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib17","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0891-5520(05)70201-4","article-title":"Resistance and treatment implications: pneumococcus, Staphylococcus aureus and gram-negative rods","volume":"3","author":"Low","year":"1998","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"Suppl. 4","key":"10.1016\/j.diagmicrobio.2007.03.024_bib20","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.1086\/382694","article-title":"Quinolone resistance among pneumococci: therapeutic and diagnostic implications","volume":"38","author":"Low","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib21","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.46.5.1295-1301.2002","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000","volume":"46","author":"Low","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib22","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious diseases society of America\/American thoracic society consensus guidelines on the management of community acquired pneumonia in adults","volume":"44","author":"Mandel","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a \u03b2-lactam\u2013based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl.","key":"10.1016\/j.diagmicrobio.2007.03.024_bib24","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in oneAmerican city: a 20-year longitudinal study, 1978\u20131997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib25","first-page":"1","article-title":"Statement on recommended use of pneumococcal conjugate vaccine","volume":"28","author":"National Advisory Committee on Immunization (NACI)","year":"2000","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib26","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib27","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/AAC.48.9.3305-3311.2004","article-title":"In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002","volume":"48","author":"Powis","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib28","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1128\/AAC.49.7.2903-2913.2005","article-title":"Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003","volume":"49","author":"Reinert","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.idc.2004.04.005","article-title":"Antimicrobial agents in the treatment of bacterial meningitis","volume":"18","author":"Sinner","year":"2004","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib30","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1001\/archinte.159.21.2576","article-title":"Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia","volume":"159","author":"Stahl","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib31","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR","volume":"40","author":"Sutcliffe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1086\/520209","article-title":"Penicillin resistance and other predictors of mortality in pneumococcal bacteremia in a population with high HIV seroprevalence","volume":"29","author":"Turret","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib33","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1378\/chest.118.6.1839-a","article-title":"Fatal pneumococcal pneumonia attributed to macrolide resistance and azithromycin monotherapy","volume":"118","author":"Waterer","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib34","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib35","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence ofmultidrug resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2007.03.024_bib36","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/AAC.47.6.1867-1874.2003","article-title":"Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002","volume":"47","author":"Zhanel","year":"2003","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889307001605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889307001605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T12:58:42Z","timestamp":1556456322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889307001605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0732889307001605"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2007.03.024","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}